Jove
Visualize
Contact Us

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

1.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K
Glucose Transporters01:27

Glucose Transporters

23.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

373
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
373
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

3.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

31.9K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Monte Carlo simulation based on first-passage distributions for spatio-temporal detection on potentiometric sensor arrays.

Analytical and bioanalytical chemistry·2026
Same author

Multidisciplinary research priorities for artificial intelligence in mental health: a call to action.

The lancet. Psychiatry·2026
Same author

Feasibility and user evaluation of HopeBot: An LLM-powered conversational chatbot for depression screening.

PLOS digital health·2026
Same author

Empowering digital health management with on-device large language models for glucose prediction: a model development and validation study.

EBioMedicine·2026
Same author

Core-shell Cu<sub>2</sub>O@UiO-66 enabled pre-concentration electrochemical sensor for rapid, sensitive detection of ammonia nitrogen in groundwater.

Talanta·2026
Same author

An Assessment of Trajectory Analysis for Disease Risk Prediction: A Scoping Review.

Studies in health technology and informatics·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 31, 2025

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.1K

GluGAN: Generating Personalized Glucose Time Series Using Generative Adversarial Networks.

Taiyu Zhu, Kezhi Li, Pau Herrero

    IEEE Journal of Biomedical and Health Informatics
    |May 3, 2023
    PubMed
    Summary

    GluGAN generates synthetic glucose time series data using generative adversarial networks (GANs) for type 1 diabetes (T1D) management. This approach enhances personalized modeling and reduces the need for extensive clinical trials.

    More Related Videos

    Simple Continuous Glucose Monitoring in Freely Moving Mice
    03:25

    Simple Continuous Glucose Monitoring in Freely Moving Mice

    Published on: February 24, 2023

    5.7K
    Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy
    07:07

    Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

    Published on: August 3, 2021

    2.8K

    Related Experiment Videos

    Last Updated: Jul 31, 2025

    A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
    08:01

    A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

    Published on: August 12, 2016

    9.1K
    Simple Continuous Glucose Monitoring in Freely Moving Mice
    03:25

    Simple Continuous Glucose Monitoring in Freely Moving Mice

    Published on: February 24, 2023

    5.7K
    Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy
    07:07

    Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

    Published on: August 3, 2021

    2.8K

    Area of Science:

    • Biomedical Engineering
    • Artificial Intelligence in Healthcare
    • Computational Biology

    Background:

    • Continuous glucose monitoring (CGM) data is crucial for data-driven diabetes management, particularly deep learning models.
    • Acquiring large-scale personalized data for type 1 diabetes (T1D) is hindered by high clinical trial costs and data privacy concerns.
    • Existing methods struggle with generating realistic and personalized glucose time series data.

    Purpose of the Study:

    • To introduce GluGAN, a novel framework for generating personalized synthetic glucose time series data.
    • To address the challenges of data acquisition and privacy in developing personalized diabetes management models.
    • To evaluate the quality and utility of synthetically generated glucose data.

    Main Methods:

    • Development of GluGAN, a generative adversarial network (GAN) framework utilizing recurrent neural network (RNN) modules.
    • Implementation of a hybrid unsupervised and supervised training approach to capture temporal dynamics.
    • Evaluation using clinical metrics, distance scores, and post-hoc RNN-based discriminative and predictive scores on three T1D datasets.

    Main Results:

    • GluGAN outperformed four baseline GAN models across all evaluated metrics on three T1D datasets.
    • Data augmentation with GluGAN significantly reduced the root mean square error (RMSE) of glucose predictors at 30 and 60-minute horizons.
    • The generated synthetic data demonstrated high quality and effectiveness for improving predictive model performance.

    Conclusions:

    • GluGAN is an effective method for generating high-quality synthetic glucose time series data.
    • The framework has the potential to aid in evaluating automated insulin delivery algorithms.
    • GluGAN can serve as a digital twin, potentially substituting for pre-clinical trials in diabetes research.